首页> 美国卫生研究院文献>Biomolecules Therapeutics >Evaluating Pharmacological Effects of Two Major Components of Shuangdan Oral Liquid: Role of Danshensu and Paeonol in Diabetic Nephropathy Rat
【2h】

Evaluating Pharmacological Effects of Two Major Components of Shuangdan Oral Liquid: Role of Danshensu and Paeonol in Diabetic Nephropathy Rat

机译:评价双丹口服液两种主要成分的药理作用:丹参素和丹皮酚在糖尿病肾病大鼠中的作用

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Shuangdan oral liquid (SDO) containing radix Salviae miltiorrhizae (Chinese name Danshen) and cortex moutan (Chinese name Mudanpi) is a traditional Chinese medicine using for treating vascular diseases. Danshensu (DSS) is a main effective monomer composition derived from radix Salviae miltiorrhizae and paeonol (Pae) from cortex moutan. Although the two herbs are widely used in traditional Chinese medicine, the pharmacological functions of their active compositions were not reported. Therefore, the research of DSS and Pae in mechanisms and pharmacodynamics interaction can provide scientific evidence to support clinical application. The diabetic nephropathy (DN) rats which were induced by streptozotocin (STZ) were treated with SDO, DSS, Pae, and DSS+Pae for eight weeks. The positive effects on DN animal models were investigated by detection of physiological and biochemical indexes and oxidative stress markers, within five treatments: SDO, DSS, Pae, DSS+Pae and insulin group. Compared with the model group, the DSS+Pae group improved the renal function, blood lipid metabolism and blood viscosity, increased the vitality of T-SOD or T-AOC and decreased the level of MDA or NO after the treatment. The study was successfully showed that the DSS+Pae group could delay the process of DN, especially in the renal injury part of histopathology changes. Our results suggest that the co-administration of DSS and Pae significantly may play a protective role in DN rats through decreasing the oxidative stress and improving the blood lipid metabolism mechanisms.
机译:丹参丹参(丹参)和牡丹皮丹(牡丹皮)的双丹口服液(SDO)是用于治疗血管疾病的中药。丹参素(DSS)是一种主要有效的单体成分,其由丹参和丹皮中的丹皮酚(Pae)衍生而来。尽管两种草药广泛用于中药中,但尚未报道其有效成分的药理作用。因此,DSS和Pae在机理和药效学相互作用方面的研究可以为支持临床应用提供科学依据。链脲佐菌素(STZ)诱导的糖尿病肾病(DN)大鼠用SDO,DSS,Pae和DSS + Pae治疗八周。通过检测SDO,DSS,Pae,DSS + Pae和胰岛素治疗这5种治疗方法,通过检测生理生化指标和氧化应激标志物来研究对DN动物模型的积极作用。与模型组相比,DSS + Pae组治疗后改善了肾功能,血脂代谢和血液黏度,增加了T-SOD或T-AOC的活力,降低了MDA或NO水平。研究成功表明,DSS + Pae组可以延迟DN的进程,尤其是在肾脏损伤部分的组织病理学改变。我们的研究结果表明,DSS和Pae的共同给药可能通过降低氧化应激和改善血脂代谢机制而在DN大鼠中起保护作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号